{"changes":[],"country":"IT","description":"NanoPhoria develops nanoparticle drug-delivery technology for inhaled treatments in respiratory and ophthalmic disease. It serves pharma partners reformulating biologics and small molecules as inhalable products. Its lipid-nanoparticle platform crosses the lung-tissue barriers where existing dry-powder inhaler tech leaves a deposition gap.","domain":"nanophoria.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":44.538473,"lng":10.935961,"location":"Modena","name":"NanoPhoria","rounds":[{"amountQuarantined":false,"amountUsd":90180000,"currency":"EUR","date":"2025-10-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-06-02","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"nanophoria-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-06-02","status":"attributed","url":null},{"fact":"existence","publisher":"nanophoria.com","retrievedAt":"2026-06-02","status":"self-reported","url":"https://nanophoria.com"},{"fact":"description","publisher":"nanophoria.com","retrievedAt":"2026-06-02","status":"self-reported","url":"https://nanophoria.com"}],"stage":"series-a","techStack":["bootstrap","jquery 1.11.1","jquery cdn","jquery migrate 3.4.1","mysql","nginx","parallax.js","php","plesk","wordpress 7.0"],"totalRaisedUsd":90180000,"updatedAt":"2026-06-02"}